Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome
Show simple item record
| dc.contributor.author |
Shurubor, Yevgeniya I |
|
| dc.contributor.author |
Matson, Wayne R |
|
| dc.contributor.author |
Willett, Walter C.
|
|
| dc.contributor.author |
Hankinson, Susan Elizabeth
|
|
| dc.contributor.author |
Kristal, Bruce S.
|
|
| dc.date.accessioned |
2011-05-19T01:22:44Z |
|
| dc.date.issued |
2007 |
|
| dc.identifier.citation |
Shurubor, Yevgeniya I., Wayne R. Matson, Walter C. Willett, Susan E. Hankinson, and Bruce S. Kristal. 2007. Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome. BMC Clinical Pathology 7: 9. |
en_US |
| dc.identifier.issn |
1472-6890 |
en_US |
| dc.identifier.uri |
http://nrs.harvard.edu/urn-3:HUL.InstRepos:4891672 |
|
| dc.description.abstract |
Background: Biomarker-based assessments of biological samples are widespread in clinical, pre-clinical, and epidemiological investigations. We previously developed serum metabolomic profiles assessed by HPLC-separations coupled with coulometric array detection that can accurately identify ad libitum fed and caloric-restricted rats. These profiles are being adapted for human epidemiology studies, given the importance of energy balance in human disease. Methods: Human plasma samples were biochemically analyzed using HPLC separations coupled with coulometric electrode array detection. Results: We identified these markers/metabolites in human plasma, and then used them to determine which human samples represent blinded duplicates with 100% accuracy (N = 30 of 30). At least 47 of 61 metabolites tested were sufficiently stable for use even after 48 hours of exposure to shipping conditions. Stability of some metabolites differed between individuals (N = 10 at 0, 24, and 48 hours), suggesting the influence of some biological factors on parameters normally considered as analytical. Conclusion: Overall analytical precision (mean median CV, ~9%) and total between-person variation (median CV, ~50–70%) appear well suited to enable use of metabolomics markers in human clinical trials and epidemiological studies, including studies of the effect of caloric intake and balance on long-term cancer risk. |
en_US |
| dc.language.iso |
en_US |
en_US |
| dc.publisher |
BioMed Central |
en_US |
| dc.relation.isversionof |
doi:10.1186/1472-6890-7-9 |
en_US |
| dc.relation.hasversion |
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2203971/pdf/ |
en_US |
| dash.license |
LAA |
|
| dc.title |
Biological variability dominates and influences analytical variance in HPLC-ECD studies of the human plasma metabolome |
en_US |
| dc.type |
Journal Article |
en_US |
| dc.description.version |
Version of Record |
en_US |
| dc.relation.journal |
BMC Clinical Pathology |
en_US |
| dash.depositing.author |
Willett, Walter C.
|
|
| dc.date.available |
2011-05-19T01:22:44Z |
|
| dash.affiliation.other |
HMS^Medicine-Brigham and Women's Hospital |
en_US |
| dash.affiliation.other |
SPH^Nutrition |
en_US |
| dash.affiliation.other |
SPH^Epidemiology |
en_US |
| dash.affiliation.other |
HMS^Medicine-Brigham and Women's Hospital |
en_US |
Files in this item
This item appears in the following Collection(s)
Show simple item record
Contact administrator regarding this item (to report mistakes or request changes)